动态增强MRI与乳腺钼靶诊断乳腺癌的价值比较

Comparison of the value of dynamic enhanced MRI and molybdenum target in the diagnosis of breast cancer

目的:探讨动态增强MRI及乳腺钼靶在乳腺癌诊断中的应用价值。方法:收治经病理检查证实的乳腺癌患者82例,术前行钼靶与MRI动态增强扫描检查,分析检查结果。结果:病理诊断显示,82例患者共存在乳腺病变肿块94处,其中,MRI动态增强扫描检查检出84处,检出率89.4%;钼靶检出89处,检出率94.7%;钼靶对乳腺癌诊断准确率78.4%,MRI动态增强扫描诊断准确率94.6%,差异有统计学意义(P<0.05)。结论:MRI动态增强扫描进行乳腺癌诊断准确率相对较高,但是钼靶检查在乳腺癌早期病变诊断中准确率相对较高。

Objective：To explore the value of dynamic enhanced MRI and molybdenum target in the diagnosis of breast cancer.Methods：82 cases of breast cancer confirmed by pathology were chosen,and they were given molybdenum target and MRI dynamic enhanced scan before operation.We analyzed the results.Results：Surgical pathology showed that there were 94 cases of breast lesions in 82 patients.Among them,84 cases were detected by MRI dynamic enhanced scan,and the detection rate was 89.4%;89 cases were detected by molybdenum target,and the detection rate was 94.7%.The accuracy rate of molybdenum target in the diagnosis of breast cancer was 78.4%,the accuracy rate of dynamic enhanced MRI in the diagnosis of breast cancer was 94.6%,and the difference was statistically significant（P〈0.05）.Conclusion：The diagnostic accuracy of MRI dynamic enhanced scan for breast cancer was relatively high,however,the diagnostic accuracy of molybdenum target for early breast cancer was relatively high.